A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205

NCT ID: NCT04241068

Last Updated: 2025-02-21

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

PHASE3

Total Enrollment

1696 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-03-02

Study Completion Date

2024-07-22

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objective is to evaluate the safety and tolerability of aducanumab over 100 weeks of treatment after a wash-out period imposed by discontinuation of feeder studies in participants who had previously received aducanumab (i.e. previously treated participants) or who had previously received placebo (i.e. treatment-naïve participants).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Alzheimer's Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Aducanumab

Participants will be administered aducanumab 10 milligrams per kilogram (mg/kg) by intravenous (IV) infusions every four weeks (Q4W) for a duration of 100 weeks during the Core Treatment Period. Eligible participants will continue to receive aducanumab 10 mg/kg IV infusion, Q4W, for 52 weeks during the Long-Term Extension (LTE) Treatment Period.

Group Type EXPERIMENTAL

Aducanumab

Intervention Type DRUG

Administered as specified in the treatment arm.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Aducanumab

Administered as specified in the treatment arm.

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

BIIB037

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Core Treatment Period:

* Participant was participating in an aducanumab clinical study at the time of the announcement of early termination (feeder studies).
* Has one care partner who, in the Investigator's opinion, has adequate contact with the participant as to be able to provide accurate information about the participant's cognitive and functional abilities.

LTE Treatment Period:

* Participant must have completed the Core study period (Week 102) and adequately tolerated 10 mg/kg of aducanumab during the Core study period in the opinion of the Investigator.
* Has one informant/care partner who, in the Investigator's opinion, has frequent and sufficient contact with the participant as to be able to provide accurate information about the participant's cognitive and functional abilities.

Exclusion Criteria

Core Treatment Period:

* Any medical or neurological condition (other than Alzheimer's Disease) that might be a contributing cause of the participant's cognitive impairment.
* Stroke or any unexplained loss of consciousness within 1 year prior to Screening.
* Clinically significant unstable psychiatric illness in past 6 months.
* History of unstable angina, myocardial infarction, advanced chronic heart failure, or clinically significant conduction abnormalities within 1 year prior to Screening.
* A seizure event that occurred after the last visit of the feeder study and before Screening for this study.
* Evidence of impaired liver function as shown by an abnormal liver function profile at Screening.
* History of or known seropositivity for HIV.
* Clinically significant systemic illness or serious infection within 30 days prior to or during Screening.
* Contraindications to having a brain magnetic resonance imaging (MRI).

LTE Treatment Period:

* Any medical or psychiatric contraindication or clinically significant abnormality that, in the opinion of the Investigator, will substantially increase the risk associated with the participant's enrollment in and completion of the study.
Minimum Eligible Age

50 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Biogen

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Medical Director

Role: STUDY_DIRECTOR

Biogen

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Alabama at Birmingham

Birmingham, Alabama, United States

Site Status

Banner Alzheimer's Institute

Phoenix, Arizona, United States

Site Status

Dignity Health

Phoenix, Arizona, United States

Site Status

Banner Sun Health Research Institute

Sun City, Arizona, United States

Site Status

Center for Neurosciences

Tucson, Arizona, United States

Site Status

Neurology Center of North Orange County

Fullerton, California, United States

Site Status

UCI MIND

Irvine, California, United States

Site Status

University of California San Diego Medical Center

La Jolla, California, United States

Site Status

Senior Clinical Trials, Inc.

Laguna Hills, California, United States

Site Status

USC Keck School of Medicine

Los Angeles, California, United States

Site Status

Mary S. Easton Center for Alzheimer's Disease Research, UCLA

Los Angeles, California, United States

Site Status

Pacific Neuroscience Medical Group

Oxnard, California, United States

Site Status

Stanford Hospital and Clinics

Palo Alto, California, United States

Site Status

Anderson Clinical Research

Redlands, California, United States

Site Status

Pacific Research Network, Inc

San Diego, California, United States

Site Status

UCSF - Memory and Aging Center

San Francisco, California, United States

Site Status

Syrentis Clinical Research

Santa Ana, California, United States

Site Status

California Neuroscience Research Medical Group Inc.

Sherman Oaks, California, United States

Site Status

University of Colorado Denver

Aurora, Colorado, United States

Site Status

IMMUNOe International Research Centers

Centennial, Colorado, United States

Site Status

Yale University

Fairfield, Connecticut, United States

Site Status

Invicro

New Haven, Connecticut, United States

Site Status

Yale University School Of Medicine

New Haven, Connecticut, United States

Site Status

Research Center for Clinical Studies, Inc.

Norwalk, Connecticut, United States

Site Status

Georgetown University Clinical Research Unit (CRU)

Washington D.C., District of Columbia, United States

Site Status

JEM Research

Atlantis, Florida, United States

Site Status

Bradenton Research Center, Inc

Bradenton, Florida, United States

Site Status

Brain Matters Research

Delray Beach, Florida, United States

Site Status

Neuropsychiatric Research Center of Southwest Florida

Fort Myers, Florida, United States

Site Status

Infinity Clinical Research, LLC

Hollywood, Florida, United States

Site Status

Jacksonville Center for Clinical Research

Jacksonville, Florida, United States

Site Status

Mayo Clinic in Florida

Jacksonville, Florida, United States

Site Status

University of Miami

Miami, Florida, United States

Site Status

Miami Jewish Health System, Inc

Miami, Florida, United States

Site Status

Renstar Medical Research

Ocala, Florida, United States

Site Status

Accelerated Enrollment Solutions (AES)

Orlando, Florida, United States

Site Status

Clinical Neuroscience Solutions, Inc.

Orlando, Florida, United States

Site Status

Accelerated Enrollment Solutions (AES)

Orlando, Florida, United States

Site Status

Palm Beach Neurological Center

Palm Beach Gardens, Florida, United States

Site Status

Quantum Laboratories Inc.

Pompano Beach, Florida, United States

Site Status

Axiom Clinical Research of Florida

Tampa, Florida, United States

Site Status

Stedman Clinical Trials, LLC

Tampa, Florida, United States

Site Status

USF Health Byrd Institute

Tampa, Florida, United States

Site Status

Meridien Research

Tampa, Florida, United States

Site Status

Premiere Research Institute

West Palm Beach, Florida, United States

Site Status

Cleveland Clinic Florida - Weston

Weston, Florida, United States

Site Status

Emory University Cognitive Neurology Clinic & ADRC

Atlanta, Georgia, United States

Site Status

Medical Research Health and Education Foundation, Inc

Columbus, Georgia, United States

Site Status

NeuroStudies.net, LLC

Decatur, Georgia, United States

Site Status

Alexian Brothers Medical Center - Neuroscience Research Institute

Elk Grove Village, Illinois, United States

Site Status

Advocate Lutheran General Hospital

Park Ridge, Illinois, United States

Site Status

Fort Wayne Neurological Center

Fort Wayne, Indiana, United States

Site Status

Indiana University School of Medicine

Indianapolis, Indiana, United States

Site Status

Josephson, Wallack, Munshower Neurology, P.C.

Indianapolis, Indiana, United States

Site Status

University of Kansas Medical Center Research Institute, Inc.

Fairway, Kansas, United States

Site Status

Ascension Via Christi Research, a division of Ascension Via Christi Hospitals Wichita, Inc.

Wichita, Kansas, United States

Site Status

Baptist Health Lexington

Lexington, Kentucky, United States

Site Status

McLean Hospital

Belmont, Massachusetts, United States

Site Status

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States

Site Status

Brigham and Women's Hospital Department of Neurology

Boston, Massachusetts, United States

Site Status

ActivMed Practices & Research, Inc.

Methuen, Massachusetts, United States

Site Status

Boston Center for Memory

Newton, Massachusetts, United States

Site Status

Donald S. Marks, M.D., P.C.

Plymouth, Massachusetts, United States

Site Status

Mayo Clinic

Rochester, Michigan, United States

Site Status

Hattiesburg Clinic, PA

Hattiesburg, Mississippi, United States

Site Status

Washington University

St Louis, Missouri, United States

Site Status

Cleveland Clinic Lou Ruvo Center for Brain Health

Las Vegas, Nevada, United States

Site Status

Las Vegas Medical Research

Las Vegas, Nevada, United States

Site Status

ActivMed Practices & Research, Inc.

Portsmouth, New Hampshire, United States

Site Status

Advanced Memory Research Inst. of NJ, PC

Toms River, New Jersey, United States

Site Status

Albany Medical College

Albany, New York, United States

Site Status

Empire Neurology, PC

Latham, New York, United States

Site Status

New York University Medical Center PRIME

New York, New York, United States

Site Status

Weill Cornell Medical College (WCMC) - Judith Jaffe Multiple Sclerosis Center (JJMSC)

New York, New York, United States

Site Status

Mount Sinai School of Medicine

New York, New York, United States

Site Status

University of Rochester

Rochester, New York, United States

Site Status

AMC Research, LLC

Charlotte, North Carolina, United States

Site Status

Raleigh Neurology Associates

Raleigh, North Carolina, United States

Site Status

Gastroenterology Associates of the Piedmont

Winston-Salem, North Carolina, United States

Site Status

Wake Forest Baptist Health

Winston-Salem, North Carolina, United States

Site Status

Cleveland Clinic Foundation

Cleveland, Ohio, United States

Site Status

Ohio State University Wexner Medical Center

Columbus, Ohio, United States

Site Status

Lynn Health Science Institute

Oklahoma City, Oklahoma, United States

Site Status

Lehigh Center for Clinical Research, LLC

Allentown, Pennsylvania, United States

Site Status

The Clinical Trial Center, LLC

Jenkintown, Pennsylvania, United States

Site Status

Penn Memory Center

Philadelphia, Pennsylvania, United States

Site Status

University of Pittsburgh

Pittsburgh, Pennsylvania, United States

Site Status

Northeastern Pennsylvania Memory and Alzheimer's Center

Wilkes-Barre, Pennsylvania, United States

Site Status

Rhode Island Mood & Memory Research Institute

East Providence, Rhode Island, United States

Site Status

Rhode Island Hospital

Providence, Rhode Island, United States

Site Status

Butler Hospital

Providence, Rhode Island, United States

Site Status

Roper St. Francis Healthcare

Charleston, South Carolina, United States

Site Status

Medical University of South Carolina (MUSC)

Charleston, South Carolina, United States

Site Status

Neurology Clinic, PC

Cordova, Tennessee, United States

Site Status

Senior Adult Specialty Research

Austin, Texas, United States

Site Status

UT Southwestern Medical Center

Dallas, Texas, United States

Site Status

Baylor College of Medicine

Houston, Texas, United States

Site Status

Clinical Trial Network

Houston, Texas, United States

Site Status

University of Utah Health Sciences Center

Salt Lake City, Utah, United States

Site Status

The Memory Clinic

Bennington, Vermont, United States

Site Status

National Clinical Research Inc.-Richmond

Richmond, Virginia, United States

Site Status

University of Washington Medical Centre

Seattle, Washington, United States

Site Status

Kingfisher Cooperative, LLC

Spokane, Washington, United States

Site Status

Medical College of Wisconsin, Inc.

Milwaukee, Wisconsin, United States

Site Status

The Prince Charles Hospital

Chermside, New South Wales, Australia

Site Status

St Vincent's Hospital Sydney

Darlinghurst, New South Wales, Australia

Site Status

Central Coast Neurosciences Research (Erina)

Erina, New South Wales, Australia

Site Status

KaRa Institute of Neurological Diseases

Macquarie Park, New South Wales, Australia

Site Status

Box Hill Hospital

Box Hill, Victoria, Australia

Site Status

Austin Health

Heidelberg West, Victoria, Australia

Site Status

Royal Melbourne Hospital

Parkville, Victoria, Australia

Site Status

Australian Alzheimer's Research Foundation

Nedlands, Western Australia, Australia

Site Status

LKH - Universitaetsklinikum Graz

Graz, , Austria

Site Status

Christian-Doppler-Klinik - Universitätsklinikum Salzburg

Salzburg, , Austria

Site Status

AKH - Medizinische Universität Wien

Vienna, , Austria

Site Status

AZ Klina

Brasschaat, , Belgium

Site Status

AZ Sint-Jan

Bruges, , Belgium

Site Status

Universitair Ziekenhuis Brussel

Brussels, , Belgium

Site Status

Universitair Ziekenhuis Gent

Ghent, , Belgium

Site Status

AZ Groeninge

Kortrijk, , Belgium

Site Status

UZ Leuven

Leuven, , Belgium

Site Status

AZ Delta

Roeselare, , Belgium

Site Status

University of Calgary - Heritage Medical Research Clinic

Calgary, Alberta, Canada

Site Status

The Medical Arts Health Research Group

Kamloops, British Columbia, Canada

Site Status

The Medical Arts Health Research Group

Penticton, British Columbia, Canada

Site Status

UBC Hospital

Vancouver, British Columbia, Canada

Site Status

Medical Arts Health Research Group

West Vancouver, British Columbia, Canada

Site Status

True North Clinical Research - Halifax Inc.

Halifax, Nova Scotia, Canada

Site Status

True North Clinical Research

Kentville, Nova Scotia, Canada

Site Status

St. Joseph's HC- Parkwood Institute

London, Ontario, Canada

Site Status

Bruyere Continuing Care

Ottawa, Ontario, Canada

Site Status

Kawartha Centre - Redefining Healthy Aging

Peterborough, Ontario, Canada

Site Status

Toronto Memory Program (Neurology Research Inc.)

Toronto, Ontario, Canada

Site Status

Toronto Sunnybrook Hospital

Toronto, Ontario, Canada

Site Status

Toronto Western Hospital

Toronto, Ontario, Canada

Site Status

Clinique de la Memoire de l'Outaouais

Gatineau, Quebec, Canada

Site Status

Institut et Clinique MoCA

Greenfield Park, Quebec, Canada

Site Status

Montreal Neurological Institute Clinical Research Unit

Montreal, Quebec, Canada

Site Status

CHU de Quebec - Hôpital de l' Enfant Jésus

Québec, , Canada

Site Status

CCBR - Ålborg - DK

Aalborg, , Denmark

Site Status

Danish Dementia Research Centre

Copenhagen, , Denmark

Site Status

CCBR - Vejle - DK

Vejle, , Denmark

Site Status

Terveystalo Ruoholahti

Helsinki, , Finland

Site Status

Itä-Suomen yliopisto, Aivotutkimusyksikkö

Kuopio, , Finland

Site Status

CRST, Clinical Research Services Turku

Turku, , Finland

Site Status

CHU Strasbourg - Hôpital Hautepierre

Strasbourg, Bas Rhin, France

Site Status

Hôpital de la Timone

Marseille, Bouches-du-Rhône, France

Site Status

Groupe Hospitalier Pellegrin - Hôpital Pellegrin

Bordeaux, Gironde, France

Site Status

Hopital Purpan

Toulouse, Haute Garonne, France

Site Status

Hôpital La Grave

Toulouse, Haute Garonne, France

Site Status

Hopital Gui de Chauliac

Montpellier, Herault, France

Site Status

CHU Rennes - Pontchaillou

Rennes, Ille Et Vilaine, France

Site Status

CHU Nantes - Hopital Nord Laënnec

Nantes, Loire Atlantique, France

Site Status

CHU Reims - Hôpital Maison Blanche

Reims, Marne, France

Site Status

CHU Lille - Hopital Roger Salengro

Lille, Nord, France

Site Status

Hôpital Lariboisière

Paris, Paris, France

Site Status

CHU de Lyon - Hopital Neurologique Pierre Wertheimer

Bron, Rhone, France

Site Status

Hôpital des Chapennes

Villeurbanne, Rhone, France

Site Status

Groupe Hospitalier Pitie-Salpetriere

Paris, , France

Site Status

Hôpital Broca

Paris, , France

Site Status

Studienzentrum fur Neurologie und Psychiatrie

Böblingen, Baden-Wurttemberg, Germany

Site Status

ISPG - Institut fuer Studien zur Psychischen Gesundheit

Mannheim, Baden-Wurttemberg, Germany

Site Status

mind mvz GmbH

Stuttgart, Baden-Wurttemberg, Germany

Site Status

Neuropoint Studienzentrum

Ulm, Baden-Wurttemberg, Germany

Site Status

Universitaetsklinikum Ulm

Ulm, Baden-Wurttemberg, Germany

Site Status

Klinikum Bayreuth GmbH- Hohe Warte

Bayreuth, Bavaria, Germany

Site Status

Bezirkskrankenhaus Guenzburg

Günzburg, Bavaria, Germany

Site Status

Klinikum rechts der Isar der TU Muenchen

Munich, Bavaria, Germany

Site Status

Institut fuer Schlaganfall- und Demenzforschung (ISD)

München, Bavaria, Germany

Site Status

Neuropraxis Muenchen Sued

Unterhaching, Bavaria, Germany

Site Status

Neuro Centrum Science GmbH, Geschaftführende Gesellschafterin Barbara Unsorg und Prüfarzt Dr. med. G

Erbach im Odenwald, Hesse, Germany

Site Status

Neurologische Gemeinschaftspraxis Kassel

Kassel, Hesse, Germany

Site Status

Klinische Forschung Hannover-Mitte GmbH

Hanover, Lower Saxony, Germany

Site Status

Universitaetsklinikum Aachen AOeR

Aachen, North Rhine-Westphalia, Germany

Site Status

Neurozentrum Bielefeld

Bielefeld, North Rhine-Westphalia, Germany

Site Status

Universitaetsklinikum Koeln

Cologne, North Rhine-Westphalia, Germany

Site Status

Universitaetsklinikum Duesseldorf AoeR

Düsseldorf, North Rhine-Westphalia, Germany

Site Status

Zentrum f. Neurologisch- Psychiatrische Studien und Begutachtung

Siegen, North Rhine-Westphalia, Germany

Site Status

Klinikum Altenburger Land GmbH

Altenburg, Thuringia, Germany

Site Status

Emovis GmbH

Berlin, , Germany

Site Status

Neurologie im Tempelhofer Hafen

Berlin, , Germany

Site Status

Charite Universitaetsmedizin Berlin - Campus Berlin Buch

Berlin, , Germany

Site Status

Ospedale degli Infermi

Ponderano, Biella, Italy

Site Status

Azienda Ospedaliera Card. G. Panico

Tricase, Lecce, Italy

Site Status

ASST di Monza

Monza, Milano, Italy

Site Status

Fondazione Istituto G.Giglio di Cefalù

Cefalù, Palermo, Italy

Site Status

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (Presidio Spedali Civili)

Brescia, , Italy

Site Status

Azienda Ospedaliero Universitaria San Martino

Genova, , Italy

Site Status

Ospedale San Raffaele

Milan, , Italy

Site Status

Fondazione IRCCS Istituto Neurologico Carlo Besta

Milan, , Italy

Site Status

AOU dell'Università degli studi della Campania Luigi Vanvitelli

Napoli, , Italy

Site Status

Azienda Ospedaliera e Universitaria di Perugia

Perugia, , Italy

Site Status

Azienda Ospedaliero Universitaria Pisana

Pisa, , Italy

Site Status

Azienda Ospedaliera Universitaria Policlinico Umberto I - Università di Roma La Sapienza

Roma, , Italy

Site Status

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Roma, , Italy

Site Status

Fondazione Santa Lucia IRCCS

Roma, , Italy

Site Status

Azienda Ospedaliera Universitaria OO. RR. S. Giovanni di Dio e Ruggi D'Aragona

Salerno, , Italy

Site Status

A.O.U. Senese Policlinico Santa Maria alle Scotte

Siena, , Italy

Site Status

Research Site

Obu-shi, Aichi-ken, Japan

Site Status

Research Site

Chiba, Chiba, Japan

Site Status

Research Site

Chiba, Chiba, Japan

Site Status

Research Site

Inzai-shi, Chiba, Japan

Site Status

Research Site

Toon-shi, Ehime, Japan

Site Status

Research Site

Fukuoka, Fukuoka, Japan

Site Status

Research Site

Kurume-shi, Fukuoka, Japan

Site Status

Research Site

Aizu-Wakamatsu, Fukushima, Japan

Site Status

Research Site

Otake-shi, Hiroshima, Japan

Site Status

Research Site

Asahikawa-shi, Hokkaido, Japan

Site Status

Research Site

Sapporo, Hokkaido, Japan

Site Status

Research Site

Amagasaki-shi, Hyōgo, Japan

Site Status

Research Site

Himeji-shi, Hyōgo, Japan

Site Status

Research Site

Himeji-shi, Hyōgo, Japan

Site Status

Research Site

Kobe, Hyōgo, Japan

Site Status

Research Site

Kita-gun, Kagawa-ken, Japan

Site Status

Research Site

Kamakura-shi, Kanagawa, Japan

Site Status

Research Site

Kyoto, Kyoto, Japan

Site Status

Research Site

Kyoto, Kyoto, Japan

Site Status

Research Site

Tsu, Mie-ken, Japan

Site Status

Research Site

Togitsu, Nagasaki, Japan

Site Status

Research Site

Nagaoka-shi, Niigata, Japan

Site Status

Research Site

Yufu-shi, Oita Prefecture, Japan

Site Status

Research Site

Kurashiki-shi, Okayama-ken, Japan

Site Status

Research Site

Okayama, Okayama-ken, Japan

Site Status

Research Site

Tsukuba, Okayama-ken, Japan

Site Status

Research Site

Osaka, Osaka, Japan

Site Status

Research Site

Suita-shi, Osaka, Japan

Site Status

Research Site

Iruma-gun, Saitama, Japan

Site Status

Research Site

Kasukabe-shi, Saitama, Japan

Site Status

Research Site

Shizuka-shi, Shizuoka, Japan

Site Status

Research Site

Shizuoka, Shizuoka, Japan

Site Status

Research Site

Bunkyō City, Tokyo-To, Japan

Site Status

Research Site

Kiyose-shi, Tokyo-To, Japan

Site Status

Research Site

Kodaira-shi, Tokyo-To, Japan

Site Status

Research Site

Yamagata, Yamagata, Japan

Site Status

Brain Research Center

Amsterdam, , Netherlands

Site Status

Amphia Ziekenhuis, Molengracht

Breda, , Netherlands

Site Status

Erasmus Medisch Centrum

Rotterdam, , Netherlands

Site Status

Podlaskie Centrum Psychogeriatrii

Bialystok, , Poland

Site Status

PALLMED Sp. z o.o.

Bydgoszcz, , Poland

Site Status

Klinika Psychiatrii Doroslych UCK

Gdansk, , Poland

Site Status

Novo-Med Zielinski i wspolnicy Sp. j.

Katowice, , Poland

Site Status

SPZOZ Centralny Szpital Kliniczny UM w Lodzi

Lodz, , Poland

Site Status

Samodzielny Publiczny Szpital Kliniczny Nr 4 w Lublinie

Lublin, , Poland

Site Status

NZOZ "NEURO-KARD", "Ilkowski i Partnerzy" Sp. Partn. Lek.

Poznan, , Poland

Site Status

Neuro-Care Gabriela Klodowska

Siemianowice Śląskie, , Poland

Site Status

Centrum Medyczne Senior

Sopot, , Poland

Site Status

Osrodek Badan Klinicznych EUROMEDIS

Szczecin, , Poland

Site Status

Centrum Medyczne NeuroProtect

Warsaw, , Poland

Site Status

NZOZ Wroclawskie Centrum Alzheimerowskie

Wroclaw, , Poland

Site Status

Hospital de Braga

Braga, , Portugal

Site Status

Centro Hospitalar e Universitário de Coimbra E.P.E - Hospitais da Universidade de Coimbra

Coimbra, , Portugal

Site Status

Hospital Beatriz Ângelo

Loures, , Portugal

Site Status

CNS-Campus Neurologico Senior

Torres Vedras, , Portugal

Site Status

Inha University Hospital

Incheon, Gyeonggi-do, South Korea

Site Status

Seoul National University Bundang Hospital

Seongnam-si, Gyeonggi-do, South Korea

Site Status

Gachon University Gil Medical Center

Incheon, , South Korea

Site Status

Konkuk University Medical Center

Seoul, , South Korea

Site Status

Asan Medical Center

Seoul, , South Korea

Site Status

Samsung Medical Center

Seoul, , South Korea

Site Status

Hospital General Universitario de Elche

Elche, Alicante, Spain

Site Status

Hospital Universitario Reina Sofia

Córdoba, Córdoba, Spain

Site Status

Policlinica Gipuzkoa

Donostia / San Sebastian, Guipuzcoa, Spain

Site Status

Clinica Universidad de Navarra

Pamplona, Navarre, Spain

Site Status

CAE Oroitu

Getxo, Vizcaya, Spain

Site Status

Hospital del Mar

Barcelona, , Spain

Site Status

Hospital de la Santa Creu i Sant Pau

Barcelona, , Spain

Site Status

Fundacio ACE

Barcelona, , Spain

Site Status

Hospital Clinic de Barcelona

Barcelona, , Spain

Site Status

Hospital Universitari de Santa Maria

Lleida, , Spain

Site Status

Complejo Hospitalario Ruber Juan Bravo

Madrid, , Spain

Site Status

Hospital Victoria Eugenia

Seville, , Spain

Site Status

Hospital Universitario Dr. Peset

Valencia, , Spain

Site Status

Hospital Universitari i Politecnic La Fe

Valencia, , Spain

Site Status

Skånes Universitetssjukhus

Malmo, , Sweden

Site Status

Sahlgrenska Universitetssjukhuset, Mölndal Sjukhus

Mölndal, , Sweden

Site Status

Karolinska Universitetssjukhuset, Huddinge

Stockholm, , Sweden

Site Status

Akademiska Sjukhuset

Uppsala, , Sweden

Site Status

Spitalzentrum Biel

Biel/Bienne, , Switzerland

Site Status

Hôpitaux Universitaires de Geneve- HUG

Geneva, , Switzerland

Site Status

Centre Hospitalier Universitaire Vaudois

Lausanne, , Switzerland

Site Status

Ospedale Regionale di Lugano

Lugano, , Switzerland

Site Status

Institut fur Regenerative Medizin-IREM Universitat Zurich, Campus Schlieren

Schlieren, , Switzerland

Site Status

Changhua Christian Medical Foundation Changhua Christian Hospital

Changhua, , Taiwan

Site Status

Kaohsiung Chang Gung Memorial Hospital

Kaohsiung City, , Taiwan

Site Status

National Cheng Kung University Hospital

Tainan City, , Taiwan

Site Status

Taipei Veterans General Hospital

Taipei, , Taiwan

Site Status

Chang Gung Memorial Hospital, Linkou

Taoyuan, , Taiwan

Site Status

Re:Cognition Health Ltd (London)

London, Greater London, United Kingdom

Site Status

Charing Cross Hospital

London, Greater London, United Kingdom

Site Status

The National Hospital for Neurology and Neurosurgery Centre

London, Greater London, United Kingdom

Site Status

Manchester Royal Infirmary

Manchester, Greater Manchester, United Kingdom

Site Status

The University of Edinburgh

Edinburgh, Lothian Region, United Kingdom

Site Status

The RICE Centre

Bath, Somerset, United Kingdom

Site Status

Queen Elizabeth University Hospital Campus

Glasgow, Strathclyde, United Kingdom

Site Status

Glasgow Memory Clinic Ltd

Motherwell, Strathclyde, United Kingdom

Site Status

Ninewells Hospital

Dundee, Tayside Region, United Kingdom

Site Status

Newcastle University

Newcastle upon Tyne, Tyne & Wear, United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Australia Austria Belgium Canada Denmark Finland France Germany Italy Japan Netherlands Poland Portugal South Korea Spain Sweden Switzerland Taiwan United Kingdom

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Document Type: Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2019-004368-22

Identifier Type: EUDRACT_NUMBER

Identifier Source: secondary_id

221AD304

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Study of AV-1959D, an Amyloid Beta Vaccine
NCT05642429 ACTIVE_NOT_RECRUITING PHASE1